In the ML program, Nick Miller MPA’22, LPS’22, ML’24, the youngest person elected to the Pennsylvania state Senate in 135 years, has discovered the profound impact that language has on the application and interpretation of the law.
The expert panel convened at the 2023 Master in Law Annual Lecture explored patent disputes over CRISPR technology.
Penn Program on Regulation hosts panel discussion on governing a fast-changing world.
Regulatory Review: Regulators Propose Updates to Community Reinvestment Act Rules, Ayo Aladesanmi MPA/ML’23
Financial regulators propose new rules to expand and modernize law that targets inequities in bank lending.
Regulatory Review: U.S. Supply Chain Regulations Seek to Improve Resilience - Ayo Aladesamni MPA/ML’23
New regulations seek to restructure global supply chains to value long-term resilience over industrial efficiency.
FDA’s approach to evidence-based decision-making may not be addressed to the right people.
At the Interfaith Commemoration and Award Ceremony, Ayo Aladesanmi ML’23, MPA’23 Spoke About the Legacy of Martin Luther King, Jr.
Bestselling author Patrick Radden Keefe was the featured speaker at the Master in Law Program’s spring lecture honoring Dr. Ronald S. Litman ML’18.
The Neurolaw Society is a student group that encourages interdisciplinary discourse across topics in law, policy, health, and neuroscience.
Crash Course: Aren Raisinghani C’19, ENG’19, GEN’21, ML’21 Helps Drive Crash Safety at Tesla, The Journal
A cross-disciplinary whiz kid, Aren Raisinghani applies his legal education and engineering background to the complexities of auto safety at Tesla.
Two students pursuing EMPA/ML degrees chatted about harnessing cross-disciplinary opportunities to chart educational paths toward informed and confident community leadership.
FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.